当前期刊: Kidney International Supplements Go to current issue    加入关注   
显示样式:        排序: IF: - GO 导出
我的关注
我的收藏
您暂时未登录!
登录
  • 更新日期:2020-02-19
  • Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes
    Kidney Int. Suppl. (IF 5.842) Pub Date : 2020-02-19
    Roberto Pecoits-Filho; Ikechi G. Okpechi; Jo-Ann Donner; David C.H. Harris; Harith M. Aljubori; Aminu K. Bello; Ezequiel Bellorin-Font; Fergus J. Caskey; Allan Collins; Alfonso M. Cueto-Manzano; John Feehally; Bak Leong Goh; Kitty J. Jager; Masaomi Nangaku; Muhibur Rahman; Manisha Sahay; Abdulkarim Saleh; Laura Sola; David W. Johnson

    A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated

    更新日期:2020-02-19
  • Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey
    Kidney Int. Suppl. (IF 5.842) Pub Date : 2020-02-19
    Valerie A. Luyckx; Brendan Smyth; David C.H. Harris; Roberto Pecoits-Filho

    Dialysis provisions and end-stage kidney disease (ESKD) care represents an important challenge, particularly in low-resource settings. The purpose of this project was to survey nephrologists from low- and lower middle-income countries about their experiences in the following domains: (i) Dialysis funding and eligibility; (ii) dialysis-procurement mechanisms; (iii) clinical protocols for dialysis; (iv)

    更新日期:2020-02-19
  • Framework for establishing integrated kidney care programs in low- and middle-income countries
    Kidney Int. Suppl. (IF 5.842) Pub Date : 2020-02-19
    Marcello Tonelli; Victoria Nkunu; Cherian Varghese; Ali K. Abu-Alfa; Mona N. Alrukhaimi; Louise Fox; John Gill; David C.H. Harris; Fan Fan Hou; Philip J. O’Connell; Harun Ur Rashid; Abdou Niang; Shahrzad Ossareh; Vladimir Tesar; Elena Zakharova; Chih-Wei Yang

    Secular increases in the burden of kidney failure is a major challenge for health systems worldwide, especially in low- and middle-income countries (LMICs) due to growing demand for expensive kidney replacement therapies. In LMICs with limited resources, the priority of providing kidney replacement therapies must be weighed against the prevention and treatment of chronic kidney disease, other kidney

    更新日期:2020-02-19
  • Global case studies for chronic kidney disease/end-stage kidney disease care
    Kidney Int. Suppl. (IF 5.842) Pub Date : 2020-02-19
    Chih-Wei Yang; David C.H. Harris; Valerie A. Luyckx; Masaomi Nangaku; Fan Fan Hou; Guillermo Garcia Garcia; Hasan Abu-Aisha; Abdou Niang; Laura Sola; Sakarn Bunnag; Somchai Eiam-Ong; Kriang Tungsanga; Marie Richards; Nick Richards; Bak Leong Goh; Gavin Dreyer; Rhys Evans; Henry Mzingajira; Marcello Tonelli

    The prevalence of chronic kidney disease and its risk factors is increasing worldwide, and the rapid rise in global need for end-stage kidney disease care is a major challenge for health systems, particularly in low- and middle-income countries. Countries are responding to the challenge of end-stage kidney disease in different ways, with variable provision of the components of a kidney care strategy

    更新日期:2020-02-19
  • Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce
    Kidney Int. Suppl. (IF 5.842) Pub Date : 2020-02-19
    Charles R. Swanepoel; Mignon I. McCulloch; Georgi Abraham; Jo-Ann Donner; Mona N. Alrukhaimi; Peter G. Blake; Sakarn Bunnag; Stefaan Claus; Gavin Dreyer; Mohammad A. Ghnaimat; Fuad M. Ibhais; Adrian Liew; Marla McKnight; Yewondwossen Tadesse Mengistu; Saraladevi Naicker; Abdou Niang; Gregorio T. Obrador; Jeffrey Perl; Fredric O. Finkelstein

    Prevention and early detection of kidney diseases in adults and children should be a priority for any government health department. This is particularly pertinent in the low-middle-income countries, mostly in Asia, Africa, Latin America, and the Caribbean, where up to 7 million people die because of lack of end-stage kidney disease treatment. The nephrology workforce (nurses, technicians, and doctors)

    更新日期:2020-02-19
  • Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis
    Kidney Int. Suppl. (IF 5.842) Pub Date : 2020-02-19
    Laura Sola; Nathan W. Levin; David W. Johnson; Roberto Pecoits-Filho; Harith M. Aljubori; Yuqing Chen; Stefaan Claus; Allan Collins; Brett Cullis; John Feehally; Paul N. Harden; Mohamed H. Hassan; Fuad Ibhais; Kamyar Kalantar-Zadeh; Adeera Levin; Abdulkarim Saleh; Daneil Schneditz; Irma Tchokhonelidze; Fredric O. Finkelstein

    Substantial heterogeneity in practice patterns around the world has resulted in wide variations in the quality and type of dialysis care delivered. This is particularly so in countries without universal standards of care and governmental (or other organizational) oversight. Most high-income countries have developed such oversight based on documentation of adherence to standardized, evidence-based guidelines

    更新日期:2020-02-19
  • Considerations on equity in management of end-stage kidney disease in low- and middle-income countries
    Kidney Int. Suppl. (IF 5.842) Pub Date : 2020-02-19
    Wim Van Biesen; Vivekanand Jha; Ali K. Abu-Alfa; Sharon P. Andreoli; Gloria Ashuntantang; Bassam Bernieh; Edwina Brown; Yuqing Chen; Rosanna Coppo; Cecile Couchoud; Brett Cullis; Walter Douthat; Felicia U. Eke; Brenda Hemmelgarn; Fan Fan Hou; Nathan W. Levin; Valerie A. Luyckx; Rachael L. Morton; Guillermo Garcia Garcia

    Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address

    更新日期:2020-02-19
  • Developing the ethical framework of end-stage kidney disease care: from practice to policy
    Kidney Int. Suppl. (IF 5.842) Pub Date : 2020-02-19
    Valerie A. Luyckx; Dominique E. Martin; Mohammed Rafique Moosa; Aminu K. Bello; Ezequiel Bellorin-Font; Tak Mao Chan; Rolando Claure-Del Granado; Walter Douthat; Somchai Eiam-Ong; Felicia U. Eke; Bak Leong Goh; Vivekanand Jha; Evie Kendal; Adrian Liew; Yewondwossen Tadesse Mengistu; Elmi Muller; Ikechi G. Okpechi; Eric Rondeau; Tushar Vachharajani

    Ethical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources